MedPath

Meir Medical Center

Meir Medical Center logo
Ownership
Private
Employees
-
Market Cap
-
Website

17 Alfa Hydroxyprogesterone Caproate Versus Natural Progesterone for the Prevention of Preterm Labor

First Posted Date
2008-12-17
Last Posted Date
2011-08-30
Lead Sponsor
Meir Medical Center
Target Recruit Count
800
Registration Number
NCT00809939
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

Diclofenac vs. Ropivacaine for Cesarean Section

Phase 4
Completed
Conditions
Cesarean Section
Interventions
Drug: Ropivacaine, Diclofenac, Water for injection
First Posted Date
2008-12-03
Last Posted Date
2010-05-04
Lead Sponsor
Meir Medical Center
Target Recruit Count
75
Registration Number
NCT00801528
Locations
🇮🇱

Meir Medical Center, Kfar-Saba, Israel

Etoricoxib Versus Gabapentin for Knee Arthroscopy

Phase 4
Completed
Conditions
Knee Arthroscopy
Interventions
Drug: Gabapentin, Etoricoxib, Sugar pill
First Posted Date
2008-11-27
Last Posted Date
2008-11-27
Lead Sponsor
Meir Medical Center
Target Recruit Count
75
Registration Number
NCT00799149
Locations
🇮🇱

Meir Medical Center, Kfar-Saba, Israel

Study Assessing the Efficacy of Etoricoxib in Female Patients With Fibromyalgia

Phase 4
Conditions
Fibromyalgia
Interventions
First Posted Date
2008-09-19
Last Posted Date
2012-08-10
Lead Sponsor
Meir Medical Center
Target Recruit Count
80
Registration Number
NCT00755521
Locations
🇮🇱

Department of Medicine 'D', Meir Medical Center, Kfar-Saba, Israel

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

Phase 2
Withdrawn
Conditions
MCL Tear
Interventions
Drug: saline
Biological: Plasma Rich in Growth Factors (PRGF)
First Posted Date
2008-08-29
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00743886
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

Platelet-rich Plasma (PRP) Treatment for Medial Retinaculum Tear Post Medial Patellar Dislocation

Phase 2
Completed
Conditions
Patella-Dislocation
Interventions
Drug: placebo
Biological: Plasma Rich in Growth Factors (PRGF)
First Posted Date
2008-08-29
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00743873
Locations
🇮🇱

Meir medical center, Kfar Saba, Israel

Platelet Rich Plasma (PRP) as a Treatment for ACHILLES Tendon Tears

Phase 2
Completed
Conditions
Achilles Tendon Tear
Interventions
Biological: placebo
Biological: PRGF
First Posted Date
2008-08-08
Last Posted Date
2013-10-24
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00731068

Preparation Rich in Growth Factors (PRGF) Treatment for Osteoarthritis of the Knee

Phase 2
Completed
Conditions
Osteoarthritis of the Knee
Interventions
Biological: PRGF
Drug: placebo
First Posted Date
2008-08-06
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
60
Registration Number
NCT00728611
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

Phase 2
Completed
Conditions
Muscle Tear
Interventions
Biological: PRGF
Biological: Placebo
First Posted Date
2008-07-31
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
50
Registration Number
NCT00726245
Locations
🇮🇱

Meir Medicak Center, Kfar Saba, Israel

Treatment of ATFL Tears With PRP

Not Applicable
Completed
Conditions
Soft Tissue Healing
Interventions
Biological: PGRF
Biological: placebo saline
First Posted Date
2008-07-31
Last Posted Date
2011-07-12
Lead Sponsor
Meir Medical Center
Target Recruit Count
30
Registration Number
NCT00725907
Locations
🇮🇱

Meir Medical Center, Kfar Saba, Israel

© Copyright 2025. All Rights Reserved by MedPath